Sun Pharma Advanced Research Company Ltd share price logo

Sparc Share Price

(SPARC)

Check the latest share price of Sparc, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.

₹145.250.48%

as on 04:01PM, 02 May 2025

NSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Sparc Performance

Get real-time share price information, day’s high and low, historical returns and market stats.

  • Day's Low

    Day's High

    ₹143.51
    Day's Price Range
    ₹147.56
  • 52 Week's Low

    52 Week's High

    ₹109.3
    52-Week Price Range
    ₹258
1 Month Return-3.17 %
3 Month Return-6.57 %
1 Year Return-35.59 %
Previous Close₹145.95
Open₹147.45
Volume3.07L
Upper Circuit₹175.14
Lower Circuit₹116.76
Market Cap₹4,713.68Cr

Sparc Fundamentals & Key Indicators

Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.

Market Cap

₹4,713.68 Cr

PE Ratio (TTM)

-12.12

Beta (LTM)

1.28

P/B Ratio

96.09

PEG Ratio

15.95

EPS (TTM)

-11.93

Sector

Pharmaceuticals

Technical Analysis

How to invest in Sparc

Investing in Sparc is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Sparc or SPARC on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Sparc or start an SIP based on the market price on each investment date.

You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Sparc with just a few clicks!

Sparc Valuation

Track how the P/E of Sparc has moved over time to understand valuation trends.

Sparc in the last 5 years

  • Overview

  • Trends

Lowest (-38.16x)

April 8, 2024

Today (-12.12x)

May 2, 2025

Industry (54.34x)

May 2, 2025

Highest (0.00x)

December 29, 2023

LowHigh

Today’s Price to Earnings Ratio: -12.12x

Sparc Financials

Get the annual and quarterly financial summary of Sparc, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹13.86Cr (-)₹16.56Cr (↑19.48%)₹16.81Cr (↑1.51%)₹12.86Cr (↓23.50%)₹14.91Cr (↑15.94%)
Net Income-₹99.65Cr (-)-₹105.79Cr (↑6.16%)-₹95.90Cr (↓9.35%)-₹107.33Cr (↑11.92%)-₹79.51Cr (↓25.92%)
Net Profit Margin-718.98% (-)-638.83% (↓11.15%)-570.49% (↓10.70%)-834.60% (↑46.30%)-533.27% (↓36.10%)
Value in ₹ crore
Details2021202220232024
Total Assets₹229.70Cr (-)₹280.08Cr (↑21.93%)₹830.12Cr (↑196.39%)₹486.34Cr (↓41.41%)
Total Liabilities₹397.95Cr (-)₹248.85Cr (↓37.47%)₹317.35Cr (↑27.53%)₹361.49Cr (↑13.91%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow-₹210.81Cr (-)-₹151.90Cr (↓27.94%)-₹208.23Cr (↑37.08%)-₹69.12Cr (↓66.81%)-₹429.43Cr (↑521.28%)

Sparc Index Inclusions

BSE Healthcare

₹41,995.12

-0.51 (-216.2%)

S&P BSE 250 SmallCap

₹6,157.39

-0.1 (-6.03%)

BSE Small-Cap

₹47,365.54

-0.07 (-34.77%)

S&P BSE 400 MidSmallCap

₹11,047.95

-0.35 (-39.29%)

BSE 500

₹34,623.50

-0.05 (-16.85%)

Sparc Earnings and Dividends

View detailed summary of the earnings and dividend history of Sparc.

  • Sun Pharma Advanced Research Company Ltd Earnings Results

    Sun Pharma Advanced Research Company Ltd’s net profit jumped 20.21% since last year same period to ₹-79.51Cr in the Q3 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 25.92% jump in its net profits since last 3-months.

    Read More about Earnings Results

Sparc Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Sparc.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
65.67%
0.00
Foreign Institutions
1.45%
0.00
Mutual Funds
1.01%
0.00
Retail Investors
31.75%
0.00
Others
0.12%
0.00

Sparc vs Peers

Compare market cap, revenue, PE, and other key metrics of Sparc with its industry peers.

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹4,713.68 Cr1.53%0.79-₹388 Cr₹75 Cr
BUY₹28,910.94 Cr139.03%0.52₹300 Cr₹1,051 Cr
BUY₹14,447.71 Cr34.97%0.57₹72 Cr₹6,702 Cr
BUY₹13,813.06 Cr40.43%0.68₹218 Cr₹1,296 Cr
BUY₹25,289.89 Cr208.61%0.55₹258 Cr₹1,375 Cr

Insights on Sun Pharma Advanced Research Company Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.51% to 1.01% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 31.46% to 31.75% in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 54.5% return, outperforming this stock by 90.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 65.67% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 141.8% return, outperforming this stock by 183.5%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 2.23% to 1.45% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, SPARC stock has moved down by -35.6%

About Sparc

Sun Pharma Advanced Research Company Ltd (“SPARC”) is a clinical stage biopharmaceutical company focused on innovation and new product development for global markets. Established in 2006, it is engaged in the creation of new drugs and delivery systems, undertaking projects in research and technology for new chemical entities (“NCEs”) and novel drug delivery systems (“NDDS”). SPARC operates in global markets including the US, India and China. It has successfully received approvals from the US FDA for various drugs such as ELEPSIA XR Levetiracetam extended-release tablets 1000 mg and 1500 mg, XELPROS Latanoprost BAKfree eyedrops and for XELPROS latanoprost ophthalmic emulsion 0.005 which was inlicensed from Sun Pharma in 2015. In 2021, it commenced the commercialization of ElepsiaTM XR to Visiox Pharma, with eligible milestone payments and royalties and acquired exclusive rights for antibody against a unique oncology target from Biomodifying. SPARC is focused on advancement of clinical trials with vodobatinib being granted orphan drug designation for the treatment of CML and it has completed phase I study of SCD044.

Revenue: ₹14.91Cr as on December 2024 (Q4 24)
Net Profit: ₹-79.51Cr as on December 2024 (Q4 24)
Listing date: 18 Jul, 2007
Chairperson Name: Dilip S Shanghvi
OrganisationSun Pharma Advanced Research Company Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Sun Pharma Advanced Research Company Ltd price today?

Sun Pharma Advanced Research Company Ltd share price today stands at ₹145.25, Open: ₹147.45, Previous Close: ₹145.95, High: ₹147.56, Low: ₹143.51, 52 Week High: ₹258, 52 Week Low: ₹109.3.

How to Buy Sun Pharma Advanced Research Company Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Sun Pharma Advanced Research Company Ltd shares

What are today's traded volumes of Sun Pharma Advanced Research Company Ltd?

Today's traded volume of Sun Pharma Advanced Research Company Ltd(SPARC) is 3.07L.

What is today's market capitalisation of Sun Pharma Advanced Research Company Ltd?

Today's market capitalisation of Sun Pharma Advanced Research Company Ltd(SPARC) is ₹4,713.68 Cr.

What is the 52 Week High and Low Range of Sun Pharma Advanced Research Company Ltd?

Sun Pharma Advanced Research Company Ltd (SPARC)
Price
52 Week High
₹258
52 Week Low
₹109.3

How much percentage Sun Pharma Advanced Research Company Ltd is down from its 52 Week High?

Sun Pharma Advanced Research Company Ltd (SPARC) share price is ₹145.25. It is down -43.70% from its 52 Week High price of ₹258

How much percentage Sun Pharma Advanced Research Company Ltd is up from its 52 Week low?

Sun Pharma Advanced Research Company Ltd (SPARC) share price is ₹145.25. It is up 32.89% from its 52 Week Low price of ₹109.3